2(5H)-Furanone,3-[(2S,12bR)-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]- (113122-67-1)

Identification
Name:	2(5H)-Furanone,3-[(2S,12bR)-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-
Synonyms:	2(5H)-Furanone,3-(1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-, (2S-trans)-;Indolo[2,3-a]quinolizine, 2(5H)-furanone deriv.; Anthirine lactone; Antirhinelactone
CAS:	113122-67-1
Molecular Formula:	C19H20 N2 O2
Molecular Structure:
Properties
Safety Data

Other Product

(2R)-2-[(2S,12bR)-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]but-3-en-1-ol
Strychnidine,10,11-didehydro-11-[(2S,3E,12bS)-3-ethylidene-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-(9CI)
methyl (2S)-2-[(2R,3Z,12bS)-3-ethylidene-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-hydroxypropanoate (non-preferred name)
methyl (2S)-2-[(2R,3E,12bS)-3-ethylidene-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-hydroxypropanoate (non-preferred name)
methyl (2R)-2-[(2S,3R,12bS)-3-ethenyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-hydroxypropanoate sulfate (2:1) (salt) (non-preferred name)
Indolo[2,3-a]quinolizine-6-carboxylic acid,2-[(1Z)-2-carboxyethenyl]-1,2,3,4,6,7,12,- 12b-octahydro-3-(hydroxymethyl)-12-methyl- ,6-methyl ester,(2S,3S,6S,12bR)-
Pyrano[3,2-a]xanthene-8,11-dione,9-[(1S,2S,3E)-2-(acetyloxy)-1,3-dimethyl-3-pentenyl]-1,2,3,4a,5,6,6a,12,12a,12b-decahydro-12-hydroxy-3-(1-hydroxy-1-methylethyl)-6a,12b-dimethyl-,(3R,4aR,6aR,12S,12aS,12bR)- (9CI)
3-(1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-1-yl)propan-1-ol
Propanedioic acid,(1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-, dimethylester, cis-
Spiro[1H,15aH-furo[2',3':7,8]indolizino[8,1-cd]carbazole-2(2aH),6'(7'H)-[4H,5H,15aH,16H]furo[2',3':7,8]indolizino[8,1-cd]pyrido[1,2,3-lm]carbazole]-7-carboxylicacid, 2',3',4,4'a,5,6,8,12'c,13,13',14,14',17',17'a-tetradecahydro-9'-methoxy-,methyl ester, (2S,2aS,3'aR,4'aR,5aR,12bR,12'bR,12'cS,15aR,15'aS,17'aS)- (9CI)
Spiro[1H,15aH-furo[2',3':7,8]indolizino[8,1-cd]carbazole-2(2aH),6'(7'H)-[4H,5H,15aH,16H]furo[2',3':7,8]indolizino[8,1-cd]pyrido[1,2,3-lm]carbazole]-7-carboxylicacid, 2',3',4,5,6,8,13,13',14,14',17',17'a-dodecahydro-9'-methoxy-, methylester, (2S,2aS,3'aR,4'aR,5aR,12bR,12'bR,12'cS,15aR,15'aS,17'aS)- (9CI)
Benz[a]anthracene-1,7,12(2H)-trione,4a-(a-D-glucopyranosyloxy)-3,4,4a,12b-tetrahydro-2,3,8-trihydroxy-3-methyl-12b-[[(2R,5R,6R)-tetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl]oxy]-5-[(2-thio-a-D-glucopyranosyl)oxy]-,(2S,3R,4aS,12bR)-
12H-1,12-Ethano-11H-pyrido[1,2,3-lm]pyrrolo- [2,3-d]carbazol-11-ol,10-[(2S,3E,12bS)-3- ethylidene-1,2,3,4,6,7,12,12b-octahydroindolo[2,- 3-a]quinolizin-2-yl]-2,3,11a,11b,13,13ahexahydro- 14-(2-hydroxyethylidene)-,(1S,- 3aR,11S,11aR,12R,13aS,14E)-
Benz[a]anthracene-1,7,12(2H)-trione,3,4,4a,12b-tetrahydro-2,3,4a,8-tetrahydroxy-3-methyl-5-(methylthio)-12b-[[(2R,5R,6R)-tetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl]oxy]-,(2S,3R,4aR,12bR)- (9CI)
2(5H)-Furanone,5-methyl-3-[12-[(2R,3S)-3-[2-[(2S,3R)-3-[(3Z)-3-tetradecen-1-yl]-2-oxiranyl]ethyl]-2-oxiranyl]dodecyl]-,rel-
(-)-2-(1α-Ethyl-1,2,3,4,6,7,12,12bα-octahydroindolo[2,3-a]quinolizin-1-yl)-2-oxoacetic acid
(7aS,12bR)-7a,12b-Dihydro-6,7a,10-trihydroxy-3,3-dimethyl-12b-(3-methyl-2-butenyl)-3H,7H-benzofuro[3,2-b]pyrano[2,3-h][1]benzopyran-7-one
2(5H)-Furanone,5-[(2E,4E,9E)-12-(3-furanyl)-2,6,9-trimethyl-2,4,9-dodecatrien-1-yl]-4-hydroxy-3-methyl-
3-ethenyl-9-methoxy-2-[(6-methoxy-2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)methyl]-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizine
5H,7H-Furo[3,2-g]pyrano[3'',2'':5',6']benzofuro[3',2':3,4]cyclobuta[1,2-b][1]benzopyran-5,7-dione,5a,5b,12a,12b-tetrahydro-4,6-dimethoxy-9,12b-dimethyl-, (5aR,5bR,12aS,12bR)-rel-